Mandibular Advancement Device for Severe Obstructive Sleep Apnea: A Case Report Indicating a Way to Personalize Treatment
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The mandibular advancement device (MAD) is a therapeutic option for obstructive sleep apnea syndrome (OSAS); however, for severe cases, it has a lower efficacy compared to continuous positive airway pressure (CPAP). This report aimed to present the efficacy of MAD in a patient with severe OSAS who refused CPAP. Video-polysomnography and polygraphy were performed before and after treatment, respectively. Three months after fitting and titrating the MAD, the apnea–hypopnea index was reduced from 56.2 events/h to 1.3 events/h and the minimum oxyhemoglobin saturation increased from 80% to 91%. Snoring time reduced from 75.2% to 0.2%. Our patient presented with low body fat, retrognathia, pharyngeal obstruction mainly along the anteroposterior axis and at the base of the tongue, and the ability to make wide protrusive movements with the jaw. In our opinion, these features could constitute a phenotype that may predict a positive response to MAD treatment even in severe cases of OSAS.
Abstract
The mandibular advancement device (MAD) is a therapeutic option for obstructive sleep apnea syndrome (OSAS); however, for severe cases, it has a lower efficacy compared to continuous positive airway pressure (CPAP). This report aimed to present the efficacy of MAD in a patient with severe OSAS who refused CPAP. Video-polysomnography and polygraphy were performed before and after treatment, respectively. Three months after fitting and titrating the MAD, the apnea–hypopnea index was reduced from 56.2 events/h to 1.3 events/h and the minimum oxyhemoglobin saturation increased from 80% to 91%. Snoring time reduced from 75.2% to 0.2%. Our patient presented with low body fat, retrognathia, pharyngeal obstruction mainly along the anteroposterior axis and at the base of the tongue, and the ability to make wide protrusive movements with the jaw. In our opinion, these features could constitute a phenotype that may predict a positive response to MAD treatment even in severe cases of OSAS.
참고문헌 (10)
- Lévy P, "Obstructive sleep apnoea syndrome", Nat Rev Dis Primers, 1, pp.15015~ (2015)[DOI]
- Ramar K, "Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy : an update for 2015", J Clin Sleep Med, 11, pp.773~827 (2015)[DOI]
- Vecchierini MF, "A custom-made mandibular repositioning device for obstructive sleep apnoea-hypopnoea syndrome : the ORCADES study", Sleep Med, 19, pp.131~140 (2016)[DOI]
- Sutherland K, "Oral appliance treatment response and polysomnographic phenotypes of obstructive sleep apnea", J Clin Sleep Med, 11, pp.861~868 (2015)[DOI]
- de Vries GE, "Long-term objective adherence to mandibular advancement device therapy versus continuous positive airway pressure in patients with moderate obstructive sleep apnea", J Clin Sleep Med, 15, pp.1655~1663 (2019)[DOI]
- Marklund M, "Non-CPAP therapies in obstructive sleep apnoea : mandibular advancement device therapy", Eur Respir J, 39, pp.1241~1247 (2012)[DOI]
- Francis CE, "Mandibular advancement devices for OSA : an alternative to CPAP?", Pulm Ther, 7, pp.25~36 (2021)[DOI]
- Camañes-Gonzalvo S, "Comparison of the phenotypic characteristics between responders and non-responders to obstructive sleep apnea treatment using mandibular advancement devices in adult patients : systematic review and metaanalysis", Sleep Med Rev, 64, pp.101644~ (2022)[DOI]
- Chen H, "Phenotypes of responders to mandibular advancement device therapy in obstructive sleep apnea patients : a systematic review and meta-analysis", Sleep Med Rev, 49, pp.101229~ (2020)[DOI]
- Glicksman A, "Body fat distribution ratios and obstructive sleep apnea severity in youth with obesity", J Clin Sleep Med, 13, pp.545~550 (2017)[DOI]